The Semantic and Aesthetic Aspects of Omission in Some of the Conditional Structures in the Holy Qur'an
Jordan Journal of Modern Languages and Literature · 01.12.2025 · 869
DOI: 10.47012/jjmll.17.4.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jordan Journal of Modern Languages and Literature, online erschienen am 01.12.2025. Verfasst von Khalid Bani Domi.
Abstract (Originalsprache)
clause), based on 40 examples selected from the Holy Qur'an. This study has concluded that omitting the conditional structure in the Holy Qur'an reveals profound meanings and aesthetic features that create a rhetorical effect, especially when the omission constitutes some ambiguity. It has also shown that omission in the conditional structure in the Qur'an contributes to the expansion of the context through the interplay between the surface structure and deep structure. Furthermore, this study has revealed that the conditional structure whose elements are omitted is more eloquent and aesthetic than those whose elements were all preserved. In addition, this study has also shown that the result clauses of the conditional particle " لو " lau "if" were omitted in all the seven verses that were revealed to the disbelievers and describe torment scenes. Finally, this study presented some recommendations for future studies.
Zitieren
APA
Domi, K. B. (2025). The Semantic and Aesthetic Aspects of Omission in Some of the Conditional Structures in the Holy Qur'an. Jordan Journal of Modern Languages and Literature, 869. https://doi.org/10.47012/jjmll.17.4.2
Vancouver
Domi KB. The Semantic and Aesthetic Aspects of Omission in Some of the Conditional Structures in the Holy Qur'an. Jordan Journal of Modern Languages and Literature. 2025:869. doi:10.47012/jjmll.17.4.2
BibTeX
@article{Domi2025,
author = {Domi, Khalid Bani},
title = {The Semantic and Aesthetic Aspects of Omission in Some of the Conditional Structures in the Holy Qur'an},
journal = {Jordan Journal of Modern Languages and Literature},
year = {2025},
pages = {869},
doi = {10.47012/jjmll.17.4.2}
}
EUVIMED